Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

PDGFR-β Rearranged Myeloid/Lymphoid Neoplasm With Eosinophilia and Monocytosis in a Toddler Managed Successfully With Imatinib Therapy.

Created on 04 Nov 2026

Authors

Neha Rastogi, Rachit Khandelwal, Dhwanee Thakkar, Satya P Yadav

Published in

Journal of pediatric hematology/oncology. Nov 03, 2026. Epub Nov 03, 2026.

Abstract

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion gene (MLN-TK) are rare in children and exceptionally uncommon in infants. We report a 17-month-old girl diagnosed with MLN-TK.
She presented with pallor, splenomegaly, anemia, leukocytosis, thrombocytopenia, eosinophilia, and monocytosis. Bone marrow showed hypercellularity with myeloid predominance and increased eosinophilic precursors without excess blasts. Fluorescence in situ hybridization demonstrated PDGFR-β rearrangement in 84% of cells, and karyotyping identified t(5;9)(q32;q34). Imatinib led to a molecular response by 3 months and sustained remission at 3 years of follow-up.
This case highlights the importance of early molecular testing in infants with eosinophilia and monocytosis, enabling the use of targeted therapy.

PMID:
42976300
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement